UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000026811
Receipt No. R000030772
Official scientific title of the study Effective and safety using antifungal drop
Date of disclosure of the study information 2017/03/31
Last modified on 2017/03/31 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effective and safety using antifungal drop
Title of the study (Brief title) antifungal drop
Region
Japan

Condition
Condition mycotic keratitis
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Effectiveness and safety of anti-fungal voriconazole instillation against fungal keratitis
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Visual acuity
Intra ocular pressure
Recurrence rate
Side effect
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Making 1.0%Voriconazole eyedrop,Voriconazole1Aand saline solution19ml, using 4times/day for 1week
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Fungal keratitis
agreed informed consent
Key exclusion criteria less than 18years old
not agreed informed consent
Target sample size 30

Research contact person
Name of lead principal investigator Yukinobu Okajima
Organization Toho university omori hospital
Division name ophthalmology
Address 6-11-1 omorinisi otaku tokyo
TEL 03-3762-4151
Email yukinobu.okajima@med.toho-u.ac.jp

Public contact
Name of contact person Yukinobu Okajima
Organization Toho university omori hospital
Division name General Affairs Division
Address 6-11-1 omorinisi otaku tokyo
TEL 03-3762-4151
Homepage URL
Email yukinobu.okajima@med.toho-u.ac.jp

Sponsor
Institute Toho university
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 03 Month 31 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2015 Year 03 Month 01 Day
Anticipated trial start date
2015 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 03 Month 31 Day
Last modified on
2017 Year 03 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030772